Saturday, August 18, 2018
 
 
Video: Page (1) of 1 - 07/25/18 Email this story to a friend. email article Print this page (Article printing at MyDmn.com).print page facebook
The Healthy WAAY: Pancreatic Cancer Treatment

By Clip Syndicate
Researchers now have a new tool to study the development of pancreatic cancer

http://eplayer.clipsyndicate.com/view/12503/7390808 Video: The Healthy WAAY: Pancreatic Cancer Treatment
Researchers now have a new tool to study the development of pancreatic cancer
http://chic.clipsyndicate.com/video/playlist/12503/7390808?cpt=8&wpid=2637 Wed, 25 Jul 2018 16:46:46 +0000 The Healthy WAAY: Pancreatic Cancer Treatment Researchers now have a new tool to study the development of pancreatic cancer http://chic.clipsyndicate.com/video/playlist/12503/7390808?cpt=8&wpid=2637 WAAY ABC Huntsville, AL pancreatic cancer causes the deaths of 95 percent of the people diagnosed with it. chemotherapy helps but is only able to extend survival for a few months. researchers have a new tool allowing them to better study how the cancer develops. it's a tough role reversal for this retired anesthesiologist . inocencio davila is now a patient with pancreatic cancer, following a bout with renal cancer. cg inocencio davila, md in: :12 out: :24 "next thing you know, i started getting jaundice, that's when i started getting concerned. she said, well you know what they say about painless jaundice and i said i know, but i don't really want to hear that." vo/narration....... innocencio is now on an aggressive treatment plan of chemotherapy and radiation, to prolong his life. cg sukeshi arora, md medical oncologist mays cancer center "so, chemotherapies are getting better to improve those numbers, but we have a long way to go." ut health san antonio in: :30 out: :35 vo/narration....... enter researcher bruno doiron . doiron is developing a new technology that allows pancreatic tumors in mice to develop with the same traits as human pancreatic cancer. cg bruno doiron, phd biomedical researcher department of medicine ut health san antonio in: :46 out: :56 "i use the mutation found in pancreatic cancer found in humans so that mimics more randomly what's happening in the cancer development." vo/narration....... doiron injects a modified virus into the mouse. that virus delivers two human cancer genetic mutations into the mouse pancreas. the human-like cancers that develop give researchers an effective way to test new drugs. it's a finding that's applauded by patients like inocencio inocencio davila, md in: 1:13 out: 1:18 "without that how can we find a treatment for the cancer that we have." vo/narration....... i'm martie salt reporting. a u-s patent is pending on the gene delivery technology developed by bruno doiron . obesity and diabetes are major risk factors for pancreatic cancer. researchers say the new technology can be used to examine





Page: 1


Related Keywords:WAAYTV_news
Related Sites: CEN - Consumer Electronics Net ,   itbusinessnet.com ,   USDailyNews ,   HTN - Health Technology Net
Related Newsletter: IBN - IT Weekly Newsletter
 
 
 
 
 
 
 
Seniors

Drugs
  • Neurovascular Devices Market High Revenue at USD 24,650 mn by 2023 | Therapeutic Application Hemorrhagic & Ischemic Strokes | Worldwide Segmentation by MRFR
  • The Alzheimer's Research and Prevention Foundation (ARPF) Announces Second Brain Longevity® Therapy Training Program in Washington D.C.
  • Image Guided Radiotherapy Market to Experience Unfaltering Growth at 15.8% CAGR to Revolutionize the Healthcare Sector by 2023
  • Disposable Negative Pressure Wound Therapy Devices Market: Global Industry Analysis (2012 - 2016) & Opportunity Assessment (2017 - 2027)
  • Elysium Health™ Announces Exclusive License for Use of Nicotinamide Riboside for the Slowing of Aging and Prevention of Age-Related Diseases from Mayo Clinic and Harvard

    Cancer
  • Biotest AG: Cytotect(R) CP prevents transmission of Cytomegalovirus (CMV) to the unborn baby in pregnant women who are infected with CMV for the first time
  • ViewRay Announces Full Exercise of Underwriters' Option to Purchase Additional Shares and Closing of Public Offering of Common Stock
  • Mirati Therapeutics Announces Presentation Of KRAS G12C Chemistry Advances At The 255th American Chemical Society (ACS) National Meeting And Exposition
  • Agenus Receives Second Milestone Payment from Merck
  • Colorado Pain Care Broadens Practice to Include Cancer Patient Treatment in Denver, CO and Surrounding Area
  •  
     
     
     
     
     





    Our Privacy Policy --- About The Health Technology - Contact Us - Advertise With Us - Privacy Guidelines